52-Week Performance Chart

Powered by FactSet Research Systems Inc

Recent Company News

More

Powered by FactSet Research Systems Inc.

Corporate Actions/Books Closed

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
TOP MUTUAL FUND HOLDERS POSITION

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol SILXY
CUSIP 827046103
DR Venue OTC
DR ISIN US8270461036
Ratio DR:ORD 1:5
Underlying ISIN AU000000SLX4
Underlying SEDOL 6111735
Country Australia
Effective Date May 17, 1999
Depositary BK (Sponsored)
Industry Electron.&ElectricEq
Books Open/Closed Open
Silex Systems is a research and development company whose primary asset is the SILEX laser uranium enrichment technology. The SILEX technology was licensed to GE-Hitachi Global Laser Enrichment LLC in the United States. The Company also has an interest in a semiconductor technology known as crystalline Rare Earth Oxides (cREO (TM)) through Translucent Inc. cREO (TM) is used for application to the manufacturing of semiconductor devices used in wireless communications, power electronics and other semiconductor industries. The Company operates in three segments, which are Silex Systems, Translucent and Silex USA.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.0000
Cancellation up to $0.0500
Cash Distribution up to $0.0200
Issuance up to $0.0500
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.0200
Rights - Issuance up to $0.0500
Stock Dividend up to $0.0500
Transfer up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Jun.25 14.25 108,483 5,424
May.25 11.58 65,030 3,423
Apr.25 9.74 97,781 4,656

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE